Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

Nipah virus is an emerging zoonotic infection that can cause severe respiratory illness and encephalitis. According to the World Health Organization, cases were first reported in 1998 and have since been documented in Bangladesh, India, Malaysia, the Philippines, and Singapore, with an estimated case fatality rate of 40%–75%. Zoonotic disease transmission remains a key epidemiological concern. As per the Nipah virus Epidemiology Forecast by Expert Market Research, ongoing surveillance is important for assessing the disease burden.

2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

Nipah Virus – Number of Cases by Year

Read more about this report - Request a Free Sample

Nipah Virus Epidemiology Forecast Report Coverage

Expert Market Research's “Nipah Virus Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of Nipah virus. It projects the future incidence and prevalence rates of Nipah virus cases across various populations. The study covers age, gender, and type as major determinants of the Nipah virus population. The report highlights patterns in the prevalence of Nipah virus over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of Nipah virus in the 8 major markets.

Regions Covered

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Nipah Virus Understanding: Disease Overview

Nipah virus disease is a serious zoonotic infection caused by Nipah virus (NiV), an enveloped RNA virus in the Henipavirus genus. Fruit bats of the Pteropus genus are the natural hosts, and transmission to humans can occur through contact with infected animals, contaminated food, or close contact with an infected person. The disease can range from asymptomatic infection to acute respiratory illness and severe encephalitis. There are no formally recognized clinical “types”; however, Nipah virus infection commonly presents with predominantly respiratory, neurological, or combined manifestations.

Key Report Insights

Parameter

Insight

Largest Patient Pool

India

Fastest Growing Country

India

High-Risk Population

Healthcare workers, caregivers, household contacts, and people with exposure to infected animals or contaminated food

Key Diagnostic Method

Real-time polymerase chain reaction (RT-PCR); ELISA may support later-stage or post-infection diagnosis

Major Risk Factor

Close exposure to infected bats, animals, contaminated food, or infected individuals

Major gap in the market

Limited availability of specific therapeutics and the need for rapid, high-containment diagnostic capacity

Nipah Virus Epidemiology Perspective

The Nipah virus epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the Nipah virus epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for Nipah virus and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

Nipah virus has a geographically concentrated epidemiological profile, with human outbreaks reported in Bangladesh, India, Malaysia, the Philippines, and Singapore. According to the World Health Organization, Bangladesh has reported outbreaks almost annually since 2001, while India has experienced periodic outbreaks.

Gender-Specific Cases of the Disease

Gender-specific patterns vary by outbreak and are not sufficient in the provided evidence to establish a consistent sex-based epidemiological trend. In the September 2023 Kerala outbreak, all six confirmed cases were male, according to the World Health Organization.

Age-Specific Cases of the Disease

The 2023 Kerala outbreak affected individuals aged 9 to 45 years. According to the World Health Organization (2023), all six laboratory-confirmed cases occurred within this age range, demonstrating infections across both pediatric and adult populations.

Ethnicity-Wise Cases of the Disease

Nipah virus is associated with substantial mortality. As per the World Health Organization (2026), the estimated case fatality rate is 40%–75%, although rates vary between outbreaks according to surveillance and clinical management.

Mortality and Survival Analysis of the Disease

Nipah virus generally produces localized outbreaks rather than sustained widespread transmission. According to the World Health Organization (2026), India has experienced recurrent but relatively limited outbreaks, with Kerala representing an important area of repeated spillover and surveillance activity.

Nipah Virus – Number of Cases by Country

Read more about this report - Request a Free Sample

Country-wise Nipah Virus Epidemiology

The Nipah virus epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country

Key Insights

United States

The United States does not represent an established area of community Nipah virus transmission. Epidemiological relevance is primarily associated with preparedness for potential imported infections, particularly through international travel from affected South and Southeast Asian regions, together with surveillance for high-consequence zoonotic diseases.

Germany

Germany is not identified among countries with established Nipah virus outbreaks. Epidemiological considerations are therefore centered on maintaining surveillance and preparedness for travel-associated or imported infections, particularly because Nipah virus outbreaks remain concentrated in South and Southeast Asia.

France

France does not have an established history of community Nipah virus outbreaks in the supplied evidence. Epidemiological preparedness is primarily relevant to international travel and the timely recognition of potential imported infections from countries where Nipah virus transmission has been documented.

Italy

Spain is not identified as a country with established Nipah virus transmission. The epidemiological context is therefore driven primarily by international surveillance, recognition of potential travel-associated infections, and preparedness for the containment of imported cases originating from affected regions.

Spain

Italy does not represent an established Nipah virus transmission setting based on the supplied evidence. Epidemiological preparedness is relevant to international travel and the capacity to identify and manage potential imported infections associated with exposure in endemic outbreak regions.

United Kingdom

No travel-associated cases have been reported in the United Kingdom, according to the UK Health Security Agency (2026). Consequently, epidemiological relevance is primarily linked to preparedness, travel-related risk assessment, and rapid management of suspected imported cases.

Japan

Japan is not identified among countries with reported human Nipah virus outbreaks. The epidemiological landscape is therefore primarily shaped by international surveillance and preparedness for potential imported infections, particularly given the concentration of documented outbreaks in South and Southeast Asia.

India

India represents a major epidemiological focus for Nipah virus because of recurrent localized outbreaks. According to the World Health Organization (2026), outbreaks have remained relatively limited in scale but have repeatedly occurred in Kerala and other states. In January 2026, two healthcare workers in West Bengal were confirmed with Nipah virus infection, while a further case was confirmed in Kozhikode, Kerala, in June 2026.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

The principal epidemiological gap is the limited availability of rapid diagnostic and disease-specific therapeutic options for Nipah virus infection. Early symptoms can resemble other febrile, respiratory, or neurological illnesses, creating a need for timely laboratory confirmation using RT-PCR and appropriate biosafety infrastructure. India represents the most relevant opportunity among the specified countries because of its recurrent outbreaks and continued need for surveillance and outbreak preparedness. Emerging opportunities include expanded molecular diagnostic capacity, improved contact-tracing systems, infection-control infrastructure, and development of Nipah-specific therapeutics and vaccines.

Nipah Virus: Treatment Overview

There is currently no licensed antiviral treatment or approved vaccine specifically for Nipah virus disease. Management therefore centers on early diagnosis, close clinical monitoring, and supportive care, particularly for patients who develop severe respiratory or neurological complications. Treatment may include oxygen therapy, respiratory support or mechanical ventilation, fluid and nutritional management, and treatment of complications such as pneumonia or cerebral edema. Experimental approaches, including monoclonal antibodies and antiviral agents such as remdesivir, remain under development or evaluation, while evidence for ribavirin is inconclusive.

Key Questions Answered

  • What is the current and projected burden of Nipah virus across the 8 major markets?
  • Which countries across the 8 major markets account for the highest Nipah virus patient populations and fastest growth rates?
  • What is the diagnosed versus undiagnosed patient population of Nipah virus across key countries in the 8 major markets?
  • Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of Nipah virus across the 8 major markets?
  • What are the major drivers contributing to the increasing burden of Nipah virus across the 8 major markets?
  • How do major comorbidities and risk factors influence Nipah virus epidemiology trends across the 8 major markets?
  • What are the regional trends in advanced disease progression, treatment uptake, and patient management of Nipah virus across the 8 major markets?
  • Which patient segments represent the highest unmet clinical need in the Nipah virus landscape across the 8 major markets?
  • Which therapeutic areas linked to Nipah virus are expected to witness the strongest growth opportunities across the 8 major markets?
  • How is the Nipah virus epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
  • Which countries across the 8 major markets offer the most attractive market opportunities based on Nipah virus epidemiology and healthcare infrastructure?
  • Which epidemiological trends are expected to influence future drug development and market access strategies for Nipah virus across the 8 major markets?

Scope of the Nipah Virus Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of Nipah virus based on several factors.
  • Nipah Virus Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The Nipah virus report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Acute Respiratory Distress Syndrome Market

Neurological Disease Treatment Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2025

Historical Period

2019-2025

Forecast Period

2026-2035

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us